Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.abbott.co.in | |
Market Cap | 54,961.00 Cr. | |
Enterprise Value(EV) | 53,009.45 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 539.11 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 47.98 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.99 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 1,609.42 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 16.07 | Calculated using Price: 25,864.85 |
Dividend Yield | 1.26 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.12 Cr. | 21,249,302 Shares |
FaceValue | 10 | |
About Abbott India Ltd. | ||
The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India. |
1 Day |
|
+0.86% |
1 Week |
|
-0.65% |
1 Month |
|
-4.33% |
3 Month |
|
+3.33% |
6 Month |
|
+15.03% |
1 Year |
|
+16.11% |
2 Year |
|
+47.10% |
5 Year |
|
+238.93% |
10 Year |
|
+1387.79% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 26.54 | 23.93 | 21.54 | 26.35 | 24.66 | 27.09 | 27.89 | 29.95 | 32.07 | |
Return on Capital Employed (%) | 39.98 | 37.55 | 33.96 | 40.61 | 37.88 | 36.54 | 37.52 | 40.53 | 42.93 | |
Return on Assets (%) | 11.2 | 13.39 | 15.12 | 18.01 | 16.9 | 18.36 | 18.78 | 19.89 | 21.71 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 938 | 1,196 | 1,387 | 1,693 | 2,009 | 2,432 | 2,602 | 2,820 | 3,189 | 3,109 | |
Non Curr. Liab. | 432 | 29 | 35 | 41 | 62 | 210 | 190 | 184 | 144 | 140 | |
Curr. Liab. | 834 | 382 | 632 | 668 | 857 | 891 | 1,031 | 1,203 | 1,206 | 1,247 | |
Minority Int. | |||||||||||
Equity & Liab. | 2,204 | 1,607 | 2,053 | 2,402 | 2,928 | 3,532 | 3,823 | 4,207 | 4,539 | 4,496 | |
Non Curr. Assets | 541 | 156 | 160 | 136 | 167 | 328 | 335 | 354 | 1,513 | 1,545 | |
Curr. Assets | 1,663 | 1,451 | 1,893 | 2,231 | 2,761 | 3,205 | 3,487 | 3,853 | 3,025 | 2,951 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2,204 | 1,607 | 2,053 | 2,402 | 2,928 | 3,532 | 3,823 | 4,207 | 4,539 | 4,496 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 2,289 | 2,615 | 2,903 | 3,299 | 3,679 | 4,093 | 4,310 | 4,913 | 5,349 | 5,753 | |
Other Income | 48 | 51 | 60 | 118 | 114 | 115 | 83 | 83 | 154 | 217 | |
Total Income | 2,338 | 2,666 | 2,963 | 3,417 | 3,793 | 4,208 | 4,393 | 4,997 | 5,503 | 5,970 | |
Total Expenditure | -1,978 | -2,251 | -2,508 | -2,775 | -3,075 | -3,337 | -3,391 | -3,832 | -4,143 | -4,350 | |
PBIDT | 360 | 415 | 455 | 641 | 718 | 871 | 1,002 | 1,165 | 1,360 | 1,620 | |
Interest | -1 | -3 | -2 | -4 | -2 | -9 | -18 | -19 | -16 | -14 | |
Depreciation | -15 | -14 | -16 | -16 | -17 | -60 | -58 | -66 | -70 | -70 | |
Taxation | -115 | -143 | -160 | -220 | -249 | -210 | -235 | -281 | -324 | -391 | |
Exceptional Items | |||||||||||
PAT | 229 | 255 | 277 | 401 | 450 | 593 | 691 | 799 | 949 | 1,146 | |
Adjusted EPS | 108 | 120 | 130 | 189 | 212 | 279 | 325 | 376 | 447 | 539 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 155 | 215 | 249 | 307 | 153 | 499 | 626 | 727 | 948 | 893 | |
Cash Fr. Inv. | -144 | -187 | -77 | -155 | -215 | -257 | -401 | -72 | -396 | -148 | |
Cash Fr. Finan. | -42 | -58 | -80 | -90 | -102 | -143 | -217 | -582 | -637 | -639 | |
Net Change | -31 | -30 | 91 | 62 | -165 | 99 | 8 | 73 | -86 | 107 | |
Cash & Cash Eqvt | 79 | 49 | 140 | 202 | 38 | 137 | 145 | 218 | 133 | 240 |
No Corporate Announcement found. |
Fri, 26 Apr 2024 |
Closing Above Previous High |
Close Within 52 Week High Zone |
High Increase in 5 Years |
CCI Bullish |
MFI Below 20 |